FDA Approved: CERDELGA — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

The FDA approved a supplemental application for CERDELGA (Eliglustat) filed by Genzyme Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Cerdelga (Eliglustat)

Snippet

SUPPL AP for CERDELGA (ELIGLUSTAT)